LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 65.61 | 770.25 | 9528 | 9736 | 0.9786 | 0.9882 | MN20160304_L02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 65.61 | 770.25 | 9420 | 9736 | 0.9675 | 0.9821 | MN20160304_L02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 67.83 | 770.25 | 8672 | 10078 | 0.8605 | 0.9206 | MN20160304_L02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 67.83 | 770.25 | 9127 | 10078 | 0.9056 | 0.9473 | MN20160304_L02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 67.83 | 770.25 | 10008 | 10078 | 0.9930 | 0.9962 | MN20160304_L02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 67.83 | 770.25 | 9891 | 10078 | 0.9814 | 0.9899 | MN20160304_L02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 70.05 | 770.25 | 8904 | 10413 | 0.8550 | 0.9183 | MN20160304_L02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 70.05 | 770.25 | 9378 | 10413 | 0.9006 | 0.9450 | MN20160304_L02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 70.05 | 770.25 | 10504 | 10413 | 1.0087 | 1.0046 | MN20160304_L02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 70.05 | 770.25 | 10285 | 10413 | 0.9877 | 0.9934 | MN20160304_L02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 72.27 | 770.25 | 9090 | 10730 | 0.8471 | 0.9145 | MN20160304_L02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 72.27 | 770.25 | 9638 | 10730 | 0.8982 | 0.9443 | MN20160304_L02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 72.27 | 770.25 | 10958 | 10730 | 1.0212 | 1.0111 | MN20160304_L02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 72.27 | 770.25 | 10854 | 10730 | 1.0115 | 1.0060 | MN20160304_L02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 74.50 | 770.25 | 9191 | 10991 | 0.8362 | 0.9088 | MN20160304_L02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 74.50 | 770.25 | 9659 | 10991 | 0.8788 | 0.9337 | MN20160304_L02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 74.50 | 770.25 | 11324 | 10991 | 1.0302 | 1.0156 | MN20160304_L02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 74.50 | 770.25 | 11231 | 10991 | 1.0218 | 1.0113 | MN20160304_L02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 76.75 | 770.25 | 9320 | 11262 | 0.8275 | 0.9045 | MN20160304_L02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 76.75 | 770.25 | 9856 | 11262 | 0.8751 | 0.9322 | MN20160304_L02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 76.75 | 770.25 | 11702 | 11262 | 1.0390 | 1.0199 | MN20160304_L02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 76.75 | 770.25 | 11480 | 11262 | 1.0193 | 1.0099 | MN20160304_L02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 78.98 | 770.25 | 9378 | 11518 | 0.8142 | 0.8974 | MN20160304_L02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 78.98 | 770.25 | 9975 | 11518 | 0.8660 | 0.9276 | MN20160304_L02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 78.98 | 770.25 | 12104 | 11518 | 1.0509 | 1.0256 | MN20160304_L02 | G14 |